These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16412816)

  • 1. Candidate risk factors for cardiovascular disease in CKD.
    De Santo NG; Cirillo M; Perna A; Iacono G; Capasso G
    Semin Nephrol; 2006 Jan; 26(1):1-2. PubMed ID: 16412816
    [No Abstract]   [Full Text] [Related]  

  • 2. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease.
    Kendrick J; Chonchol MB
    Nat Clin Pract Nephrol; 2008 Dec; 4(12):672-81. PubMed ID: 18825155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney function, electrocardiographic findings, and cardiovascular events among older adults.
    Kestenbaum B; Rudser KD; Shlipak MG; Fried LF; Newman AB; Katz R; Sarnak MJ; Seliger S; Stehman-Breen C; Prineas R; Siscovick DS
    Clin J Am Soc Nephrol; 2007 May; 2(3):501-8. PubMed ID: 17699457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk among adults with chronic kidney disease, with or without prior myocardial infarction.
    Wattanakit K; Coresh J; Muntner P; Marsh J; Folsom AR
    J Am Coll Cardiol; 2006 Sep; 48(6):1183-9. PubMed ID: 16979003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CARI guidelines. Cardiovascular risk factors. Lipid-lowering therapy in patients with chronic kidney disease.
    Walker R;
    Nephrology (Carlton); 2005 Dec; 10 Suppl 5():S231-4. PubMed ID: 16371108
    [No Abstract]   [Full Text] [Related]  

  • 6. The unique character of cardiovascular disease in chronic kidney disease and its implications for treatment with lipid-lowering drugs.
    Nogueira J; Weir M
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):766-85. PubMed ID: 17699494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction links cardiovascular disease to pediatric chronic kidney disease: the role of nitric oxide deficiency.
    Tain YL
    Acta Paediatr Taiwan; 2007; 48(5):246-50. PubMed ID: 18254572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk in Chinese patients with chronic kidney diseases: where do we stand?
    Hou FF
    Chin Med J (Engl); 2005 Jun; 118(11):883-6. PubMed ID: 15978187
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of pulse pressure on cardiovascular risk in chronic kidney disease patients.
    Fernandez-Fresnedo G; Rodrigo E; de Francisco AL; de Castro SS; Castañeda O; Arias M
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S246-9. PubMed ID: 17130269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutrition interventions to address cardiovascular outcomes in chronic kidney disease.
    Beto JA; Bansal VK
    Adv Chronic Kidney Dis; 2004 Oct; 11(4):391-7. PubMed ID: 15492977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia and cardiovascular risk: the lesson of the CREATE Trial.
    Locatelli F; Del Vecchio L; Pozzoni P
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S262-6. PubMed ID: 17130272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular, renal and other chronic diseases. Early intervention is necessary in chronic kidney disease].
    Martín de Francisco AL; Aguilera L; Fuster V
    Nefrologia; 2009; 29(1):6-9. PubMed ID: 19240765
    [No Abstract]   [Full Text] [Related]  

  • 13. [Risk of cardiovascular disease associated to chronic renal disease. Prevalence and control degree of classical risk factors].
    García de Vinuesa S; Gómez-Campderá F; Goicoechea MA; Luño J
    Nefrologia; 2005; 25 Suppl 4():18-22. PubMed ID: 16392319
    [No Abstract]   [Full Text] [Related]  

  • 14. p-Cresol sulfate: further understanding of its cardiovascular disease potential in CKD.
    Winchester JF; Hostetter TH; Meyer TW
    Am J Kidney Dis; 2009 Nov; 54(5):792-4. PubMed ID: 19853197
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic kidney disease increases cardiovascular mortality in 80-year-old subjects in Japan.
    Kagiyama S; Matsumura K; Ansai T; Soh I; Takata Y; Awano S; Sonoki K; Yoshida A; Takehara T; Iida M
    Hypertens Res; 2008 Nov; 31(11):2053-8. PubMed ID: 19098377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary heart disease in patients with chronic kidney disease.
    Dennis VW
    J Am Soc Nephrol; 2005 Nov; 16 Suppl 2():S103-6. PubMed ID: 16251244
    [No Abstract]   [Full Text] [Related]  

  • 17. Arterial calcification and stiffness in chronic kidney disease.
    Kerr PG; Guerin AP
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):683-7. PubMed ID: 17581230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods.
    Imai E; Matsuo S; Makino H; Watanabe T; Akizawa T; Nitta K; Iimuro S; Ohashi Y; Hishida A;
    Hypertens Res; 2008 Jun; 31(6):1101-7. PubMed ID: 18716357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney And Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation.
    Brosius FC; Hostetter TH; Kelepouris E; Mitsnefes MM; Moe SM; Moore MA; Pennathur S; Smith GL; Wilson PW; ; ; ; ;
    Circulation; 2006 Sep; 114(10):1083-7. PubMed ID: 16894032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease.
    Roberts MA; Hare DL; Ratnaike S; Ierino FL
    Am J Kidney Dis; 2006 Sep; 48(3):341-60. PubMed ID: 16931208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.